Protecting teens from meningococcal disease

ST. LOUIS – With teenagers, there are certain things that come in non-negotiable pairs: a new driver's license and extra insurance, a cellphone and social media.

But parents may not be aware of one particularly crucial pair – two separate vaccines to help protect against the most common groups of meningococcal disease: one vaccine that helps protect against groups A, C, W and Y, and a separate vaccine that helps protect against group B.

The group B disease accounts for nearly 70 percent of all US meningococcal cases in 16- to 23-year-old adolescents and young adults. It also has been the cause of all outbreaks of meningococcal disease at US colleges—including Mizzou—between 2011 and 2018.

Dr. Tamera Coyne-Beasley, professor of pediatrics and internal medicine at the University of Alabama, joins Fox 2 News live via satellite to discuss the risks and complications of meningococcal disease, as well as early symptoms and the best protection against it.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.